Clinical Trial Update: Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two bowel-prep regimens using polyethylene glycol with ascorbate, with and without bisacodyl, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma
• Inflammatory Bowel Disease

Drugs mentioned

• Bisacodyl (bisacodyl)
• Polyethylene glycol-ascorbate solution (PEG-Asc) (Polyethylene glycol with ascorbate)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Bowel Disease, Colon Adenoma | Phase 3 | Status: COMPLETED